Skip to main content
. 2017 Jun 29;8(40):67851–67860. doi: 10.18632/oncotarget.18889

Table 2. Patient characteristics according to different breast cancer subtypes.

Characteristic HR+/HER2- HR+/HER2+ HR-/HER2+ HR-/HER2-
No surgery (%) Surgery (%) P value No surgery (%) Surgery (%) P value No surgery (%) Surgery (%) P value No surgery (%) Surgery (%) P value
Age (years)
 <35 94 (2.4) 52 (3.0) < 0.001 47 (4.7) 45 (8.4) < 0.001 21 (4.0) 26 (8.1) 0.009 27 (3.5) 24 (4.4) 0.031
 35-50 636 (16.6) 424 (24.5) 216 (21.7) 145 (27.0) 120 (22.8) 86 (26.9) 157 (20.5) 142 (26.1)
 >50 3107 (81.0) 1253 (72.5) 732 (73.6) 347 (64.6) 386 (73.2) 208 (65.0) 583 (76.0) 378 (69.5)
Race
 White 2977 (78.0) 1346 (78.1) 0.373 735 (74.5) 402 (74.9) 0.373 378 (72.1) 221 (69.5) 0.231 513 (67.0) 364 (67.0) 0.863
 Black 562 (14.7) 237 (13.7) 180 (18.2) 89 (16.6) 98 (18.7) 56 (17.6) 206 (26.9) 142 (26.2)
 Other 279 (7.3) 141 (8.2) 72 (7.3) 46 (8.6) 48 (9.2) 41 (12.9) 47 (6.1) 37 (6.8)
Grade
 Well differentiated 354 (12.2) 169 (10.4) < 0.001 17 (2.1) 8 (1.6) < 0.001 1 (0.2) 3 (1.0) 0.042 14 (2.3) 3 (0.6) < 0.001
 Moderately differentiated 1547 (53.5) 733 (45.2) 339 (42.1) 162 (32.1) 123 (29.2) 67 (22.3) 136 (22.3) 62 (12.1)
 Poorly/undifferentiated 989 (34.2) 719 (44.4) 450 (55.8) 334 (66.3) 297 (70.5) 230 (76.7) 459 (75.4) 449 (87.4)
Tumor size (cm)
 ≤2 534 (18.5) 261 (16.0) 0.074 128 (17.1) 82 (16.6) 0.074 50 (13.2) 53 (18.5) 0.164 98 (17.3) 58 (11.6) 0.018
 >2-5 1401 (48.4) 794 (48.6) 375 (50.0) 241 (48.9) 175 (46.1) 127 (44.3) 242 (42.7) 212 (42.4)
 >5 959 (33.1) 578 (35.4) 247 (32.9) 170 (34.5) 155 (40.8) 107 (37.3) 227 (40.0) 230 (46.0)
Nodal stage
 N0 948 (28.5) 290 (17.1) < 0.001 208 (23.4) 90 (17.2) < 0.001 76 (16.1) 47 (15.1) < 0.001 133 (19.3) 101 (19.1) < 0.001
 N1 1721 (51.7) 637 (37.6) 483 (54.5) 210 (40.2) 264 (55.9) 115 (37.0) 363 (52.8) 213 (40.3)
 N2 304 (9.1) 345 (20.4) 93 (10.5) 104 (19.9) 51 (10.8) 65 (20.9) 48 (7.0) 84 (15.9)
 N3 356 (10.7) 420 (24.8) 103 (11.6) 119 (22.8) 81 (17.2) 84 (27.0) 144 (20.9) 131 (24.8)
Marital status
 Unmarried 2064 (57.1) 800 (48.8) < 0.001 528 (56.2) 241 (47.1) < 0.001 274 (55.4) 140 (47.3) 0.028 426 (58.2) 278 (53.2) 0.076
 Married 1551 (42.9) 838 (51.2) 412 (43.8) 271 (52.9) 221 (44.6) 156 (52.7) 306 (41.8) 245 (46.8)

HER2, human epidermal growth factor receptor; HR, hormone receptor.